CLINICAL TRIALS: PHASE 3

Also available here as a PDF download:

Pfizer BionTech (mRNA Therapy)

Actual Study Start Date: April 29, 2020

Estimated Primary Completion Date: October 29, 2021

Estimated Study Completion Date: April 6, 2023

https://clinicaltrials.gov/ct2/show/NCT04368728

Moderna (mRNA Therapy)

Actual Study Start Date: July 27, 2020

Estimated Primary Completion Date: October 27, 2022

Estimated Study Completion Date: October 27, 2022

https://www.clinicaltrials.gov/ct2/show/NCT04470427

Oxford-AstraZeneca (Viral Vector Therapy)

Actual Study Start Date: August 28, 2020

Estimated Primary Completion Date: March 16, 2021

Estimated Study Completion Date: February 14, 2023

https://clinicaltrials.gov/ct2/show/NCT04516746

Janssen-Johnson & Johnson (Viral Vector Therapy)

Actual Study Start Date: September 7, 2020

Estimated Primary Completion Date: January 22, 2021

Estimated Study Completion Date: January 2, 2023

https://clinicaltrials.gov/ct2/show/NCT04505722

CoronaVac (Sinovac) (Conventional Vaccine)

Actual Study Start Date: July 21, 2020

Estimated Primary Completion Date: December 17, 2020

Estimated Study Completion Date: February 2022

https://www.clinicaltrials.gov/ct2/show/NCT04456595